中国中药(00570)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00570 中国中药

已收盘 11-05 16:08:17

1.230

+0.035

+2.93%

最高1.240	最低1.195	成交量942.60万
今开1.195	昨收1.195	日振幅3.77%
总市值61.94亿	流通市值61.94亿	总股本50.36亿
成交额1,156万	换手率0.19%	流通股本50.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00570","market":"HK","secType":"STK","nameCN":"中国中药","latestPrice":1.23,"timestamp":1793866097002,"preClose":1.195,"halted":0,"volume":9426000,"delay":0,"changeRate":0.029288702928870224,"floatShares":5035801852,"shares":5036000000,"eps":-0.0679,"marketStatus":"已收盘","change":0.035,"latestTime":"11-05 16:08:17","open":1.195,"high":1.24,"low":1.195,"amount":11558612,"amplitude":0.037657,"askPrice":1.23,"askSize":42000,"bidPrice":1.225,"bidSize":60000,"shortable":3,"etf":0,"ttmEps":-0.231648,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":5,"adr":0,"listingDate":734112000000,"exchange":"SEHK","adjPreClose":1.195,"openAndCloseTimeList":[[1793842200000,1793851200000],[1793854800000,1793865600000]],"volumeRatio":1.854928,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00570","defaultTab":"news","newsList":[{"id":"1129747517","title":"中国中药10月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1129747517","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129747517?lang=zh_cn&edition=full","pubTime":"2026-11-02 16:47","pubTimestamp":1793609254,"startTime":"0","endTime":"0","summary":"中国中药(00570)于2026年11月2日披露了截至2026年10月31日的月报表。公告显示，公司法定/注册股本无变动，报告期末已发行股份数量与上月底相同，均为5,035,801,852股，且无库存股份。\n根据报告期内的相关数据显示，公司未进行额外的股份发行、购回或注销，也无任何股份期权、可换股票据及其他股权激励安排的变动。公告指出，目前公司股本维持稳定，并仍符合香港联交所提出的公众持股量要求。\n本次公告由公司秘书伍秀薇正式签署。公司亦声明将继续严格遵守香港联交所《上市规则》及相关法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677481109","title":"ESMO年会开幕，创新药快速拉升，恒生生物科技指数翻红","url":"https://stock-news.laohu8.com/highlight/detail?id=2677481109","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677481109?lang=zh_cn&edition=full","pubTime":"2026-10-23 13:56","pubTimestamp":1792734960,"startTime":"0","endTime":"0","summary":"10月23日午后，港股三大指数集体拉升，恒生科技指数一度涨超2%，恒生国企指数、恒生指数跟涨；恒生生物科技指数午后翻红，亚盛医药、翰森制药、科伦博泰生物、先声药业、康方生物等盘中涨幅 ...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261023/c681018111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02359","03347","06606","IBBQ","01666","06978","03737","06160","159992","02273","MEDX","03613","02269","03759","01643","BK1161","00570","09926","06127","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675455167","title":"【券商聚焦】中信证券：市场风格趋于谨慎 中药高股息标的关注度持续上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2675455167","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675455167?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:52","pubTimestamp":1792111979,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，近期，市场风格趋于谨慎，中药高股息标的关注度持续上升。在此背景下，中药板块凭借\"低估值+高股息+成本端改善\"三重属性，成为具备高确定性的细分投资板块。该机构梳理两条投资主线：1）高股息率、业绩稳健标的。2）业绩边际向好、股息率具备一定吸引力的标的。风险因素：渠道库存积压的风险；业绩不及预期的风险；成本上涨的风险；集采不及预期的风险；重大支出后降低股息率的风险。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK0183","BK1219","BK1197","LU1781817850.SGD","LU1720050803.USD","03613","BK1147","LU2148510915.USD","00570","LU1794554557.SGD","BK1570","LU2289578879.USD","02877","FTDS","LU1146622755.USD","LU2580892862.HKD","BK1564","BK1515","EASY","PRIZ","LU0405327494.USD","LU1580142542.USD","01643","BK1521","LU1820825898.SGD","BK1516","02161","159207","BK0276","QUSA","BK0012","LU0405327148.USD","LU1064131003.USD","PY","LU1064130708.USD","00874","LU1255011170.USD","LU1328615791.USD","CGVV","BK0196","LU1997244956.HKD","KCE","BK1191","ABEQ","06030","600030","BK0188","LU2580892789.USD","02273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044541","title":"中医药板块普涨 绿叶制药（02186）涨2.23%  机构指板块有望迎估值与业绩双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044541","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673044541?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:45","pubTimestamp":1791423956,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股中医药板块盘初普涨，截至发稿，中国中药 涨4.98%，吉林长龙药业涨3.23%，绿叶制药涨2.23%，白云山涨1.84%，神威药业涨1.42%，华润医药涨1.05%。随着基药目录红利的Q4落地、库存周期的边际改善以及成本红利的持续释放，板块有望迎来估值与业绩的双重修复。OTC板块核心变量是成本下行和渠道去库，Q4呼吸系统疾病发病率若季节性回升，感冒呼吸类OTC终端动销有望回暖；消费中药若消费环境边际回暖，品牌中药的收入端弹性较大。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993277","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1515","02877","03320","08049","BK1521","BK1191","BK1606","00874","00570","BK1583","BK1197","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161271572","title":"中国中药更新9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161271572","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161271572?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:38","pubTimestamp":1790930312,"startTime":"0","endTime":"0","summary":"中国中药控股有限公司（股票代码：00570）于2026年10月2日披露了截至2026年9月30日的股份变动月报表。公告显示，公司在报告期内保持股本结构稳定，已发行普通股股数与上月末保持相同，未发生新增发行、购回或注销，也不存在库藏股。\n根据公告，截至2026年9月30日，公司普通股已发行股份数量为5,035,801,852股，与8月底的数据一致，未出现可换股票据、股票期权或其他权证的相关变化。公司强调其公共持股量符合香港联交所《上市规则》的最低规定。\n公司表示，将继续严格遵守香港联交所《上市规则》及相关法律法规，保障投资者合法权益。本次公告由公司秘书伍秀薇签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169455367","title":"中国中药2026年中期营收54.38亿元，同比下降27.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169455367","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169455367?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:27","pubTimestamp":1790587636,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，中国中药实现营收54.38亿元，同比下降27.1%。毛利为25.81亿元，同比下降29.0%，毛利率为47.5%，相比上年同期减少1.2个百分点。经营活动产生的现金流净额为7.53亿元，同比下降18.6%。中药材生产及经营：实现营收1.90亿元，同比下降57.5%，占总营收比重3.5%。费用结构方面，销售及分销成本18.90亿元，同比下降26.1%；行政支出5.52亿元，同比上升10.3%；研发投入1.88亿元，同比下降26.8%，主要用于中药新药创制和中药标准化研究。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"中国中药2026年中期营收54.38亿元，同比下降27.1%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642784","title":"中国中药(00570.HK)附属签订车间改造项目工程总承包合同及产能提升技术改造项目工程总承包合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642784","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667642784?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:32","pubTimestamp":1789475579,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1606","00570","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147670501","title":"中国中药子公司签逾2,190万元改扩建合同 涉关连交易免独立股东批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1147670501","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147670501?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:32","pubTimestamp":1789475521,"startTime":"0","endTime":"0","summary":"2026年9月15日，中国中药控股有限公司公告称，其全资附属公司山东一方制药有限公司及国药集团中联药业有限公司分别与中国医药集团联合工程有限公司签订工程总承包合同，合计金额约2,190.58万元，构成关连交易。公司表示，上述改造及产能提升项目旨在补充山东一方中药饮片产能、提升中联药业异维A酸红霉素凝胶等产品产能，并改善安全及设施条件，以满足市场需求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102382871","title":"中国中药旗下子公司签约山东益方改造项目，合同金额1060万元及其他事项","url":"https://stock-news.laohu8.com/highlight/detail?id=1102382871","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102382871?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:31","pubTimestamp":1789475470,"startTime":"0","endTime":"0","summary":"中国中药发布公告称，其子公司精方药业已就山东益方改造项目达成承包协议。该项目合同总金额为人民币1060万元。值得注意的是，此次签约标志着公司在区域业务拓展上迈出了新的一步。除这一核心项目外，公告还披露了其他相关事项，进一步丰富了本次信息披露的内容维度。需关注的是，合同履行过程中仍存在原材料价格波动、施工进度不确定性等潜在风险因素。公司表示，将严格按照合同条款推进项目执行，确保按期保质完成各项建设任务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","BK1606","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127368113","title":"中国中药（00570）1.1类中药创新药“醒脾解郁片”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1127368113","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127368113?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:51","pubTimestamp":1788526274,"startTime":"0","endTime":"0","summary":"2026年9月4日，中国中药控股有限公司发布自愿性公告称，其附属公司国药集团同济堂（贵州）制药有限公司申报的1.1类中药创新药“醒脾解郁片”已获国家药品监督管理局批准上市，药品上市许可持有人为同济堂制药。该药品为此前公告中的“郁枢达片”，此次获批系国家药监局完成技术审评、现场核查及抽样检验后所作决定。公告显示，“醒脾解郁片”主要功效为醒脾化湿、理气解郁，适用于轻、中度抑郁症患者。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334496","title":"中国中药(00570)：1.1类中药创新药醒脾解郁片获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334496","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664334496?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:50","pubTimestamp":1788526251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国中药(00570)发布公告，有关国家药监局受理集团的附属公司国药集团同济堂（贵州）制药有限公司（同济堂制药）的1.1类中药创新药郁枢达片注册上市申请。经国家药监局完成技术审评、现场核查、抽样检验等一系列工作程序，同济堂制药申报的1.1类中药创新药醒脾解郁片（即先前公告所称“郁枢达片”，为该药品获国家药监局核准的规范通用名称）已获得批准上市，药品上市许可持有人为同济堂制药。醒脾解郁片具有醒脾化湿、理气解郁的功效，用于轻、中度抑郁症，症状为情绪郁闷、低落，表情淡漠、倦怠乏力、失眠多梦、少气懒言、食少纳呆，头重肢困、 口中黏腻、面色晦暗，舌淡苔白腻或灰腻、脉滑或弦。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","MEDX","IBBQ","159992","BK1574","LNGR","BK1606","00570","06978","IPOS","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140699022","title":"中国中药8月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1140699022","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140699022?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:35","pubTimestamp":1788255339,"startTime":"0","endTime":"0","summary":"中国中药（00570）于2026年9月1日向香港联交所提交2026年8月31日止股份变动月报表。报告显示，截至本月末，公司普通股已发行股份维持5,035,801,852股，库存股份数量为0，与上月底持平。\n月报中未披露任何新增发行、购回或注销股份情况，也未列示任何与期权或股权激励计划相关的变动。有关注意事项包括：公司确认其公开发售股份比例符合适用的最低公众持股量要求。报告另无涉及公司发行人股份的其他回复、权证或可换股票据的订立、行使及注销等安排。\n公告显示，中国中药继续遵守香港联交所《上市规则》和相关法律规定，其股本结构在当月保持不变。该公告由公司秘书伍秀薇签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093482","title":"中国中药(00570)发布中期业绩 股东应占亏损7.76亿元 同比扩大619.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662093482?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:56","pubTimestamp":1787921819,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国中药(00570)发布截至2026年6月30日止6个月中期业绩，营业额54.38亿元(人民币，下同)，同比减少27.1%;股东应占亏损7.76亿元，同比扩大619.3%;每股基本亏损15.42分。公告称，报告期内，集团营业收入同比下降27.1%，主要是中药配方颗粒业务受行业政策调整及市场环境变化的影响，终端需求下降，本期销量减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1515","BK1191","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103049295","title":"中国中药2026年上半年营收54.38亿元，经调整净亏损7.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103049295","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103049295?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:13","pubTimestamp":1787919208,"startTime":"0","endTime":"0","summary":"中国中药公告显示，2026年上半年公司实现营收54.38亿元，同比下降27.1%。经调整净亏损7.76亿元，同比下降619.3%。毛利25.81亿元，较去年同期下滑29.0%，毛利率约为47.5%，较去年同期下降1.2个百分点。中药材生产及经营：营收1.90亿元，同比下降57.5%，毛利率4.8%，较上年同期减少5.0个百分点。中医药大健康：营收0.93亿元，同比下降23.5%，毛利率33.8%，同比上升3.0个百分点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"中国中药2026年上半年营收54.38亿元，经调整净亏损7.76亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123509844","title":"中国中药（00570）将于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1123509844","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123509844?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:01","pubTimestamp":1787043661,"startTime":"0","endTime":"0","summary":"中国中药（00570）8月18日公告称，公司董事会会议定于2026年8月28日（星期五）举行，届时将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩并对外发布。该次会议亦将处理其他董事会常规事务。\n公告显示，公司董事会目前共有12名成员，包括3名执行董事（郭晋红、李鸿坚及彭力），5名非执行董事（李向荣、祖敬、许京辉、陈坤及黄灝），以及4名独立非执行董事（谢荣、余梓山、秦岭及李伟东）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158793561","title":"中国中药7月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1158793561","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158793561?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:57","pubTimestamp":1785747449,"startTime":"0","endTime":"0","summary":"2026年8月3日，中国中药（00570）发布2026年7月股份变动月报。公告显示，截至2026年7月31日，公司已发行股份（不包括库存股份）5,035,801,852股，库存股份为0股，已发行股份总数同样为5,035,801,852股，当月无新增发行、购买或注销，股本结构维持平稳。\n公告同时显示，公司已确认满足香港联交所规定的最低公众持股量要求。未见关于股份期权、股权激励计划或其他相关协议的变动信息。\n本次公告由公司秘书伍秀薇于2026年8月3日签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652391261","title":"港股异动 | 中国中药(00570.HK)盈警后跌超7% 预计上半年亏损约8亿元至8.5亿元 业态影响导致公司商誉减值","url":"https://stock-news.laohu8.com/highlight/detail?id=2652391261","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652391261?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:17","pubTimestamp":1784517461,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00570","BK1606","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128681","title":"中国中药(00570)发盈警 预计上半年亏损约8亿元至8.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128681","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652128681?lang=zh_cn&edition=full","pubTime":"2026-07-17 21:35","pubTimestamp":1784295329,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国中药 发布公告，预期集团截至2026年6月30日止六个月亏损约为人民币8亿元至8.5亿元，去年同期亏损约人民币1.42亿元。董事会强调，上述商誉减值属非现金性质，乃为使集团财务状况未来可取得改善而采取的必要措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"中国中药(00570)发盈警 预计上半年亏损约8亿元至8.5亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1606","BK1515","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176450848","title":"中国中药(00570)发布盈利预警：上半年预亏约8亿元至8.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176450848","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176450848?lang=zh_cn&edition=full","pubTime":"2026-07-17 21:30","pubTimestamp":1784295051,"startTime":"0","endTime":"0","summary":"中国中药控股有限公司 7月17日公告，根据未经审计的综合管理账目初步评估，预计截至2026年6月30日止六个月将录得净亏损约8亿元至8.5亿元；上年同期亏损约1.42亿元。\\n\\n公告称，上述商誉减值为非现金性质。\\n\\n公司计划于2026年8月底前披露截至2026年6月30日止六个月的中期业绩。公司提醒股东及潜在投资者在买卖公司股份时保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146526446","title":"中国中药（00570）公布董事会成员及委员会职务分配","url":"https://stock-news.laohu8.com/highlight/detail?id=1146526446","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146526446?lang=zh_cn&edition=full","pubTime":"2026-07-17 21:30","pubTimestamp":1784295043,"startTime":"0","endTime":"0","summary":"中国中药控股有限公司于2026年7月17日在香港发布公告，披露最新董事名单及其在董事会各专门委员会中的任职情况。董事会下设审核委员会、薪酬与考核委员会、提名委员会及战略委员会共4个专门委员会。郭晋红担任提名委员会主席及战略委员会主席。余梓山在四个委员会均任委员。公司表示，上述董事会及委员会安排已于公告日生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-tcm.com.cn","stockEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0127},{"period":"3month","weight":-0.1672},{"period":"6month","weight":-0.3012},{"period":"1year","weight":-0.4827},{"period":"ytd","weight":-0.4282}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国中药控股有限公司是一家主要从事中药制造及销售的投资控股公司。该公司通过四个分部运营业务。一方分部主要从事中药配方颗粒、中药大健康产品及中药饮片的生产及销售。天江分部主要从事中药配方颗粒、中药饮片及中药大健康产品的生产及销售。该分部还透过其线下医疗机构提供中医药相关的医疗保健解决方案,包括中医问诊诊断、中医理疗、中药配方颗粒处方药等产品。同济堂分部主要从事中药配方颗粒、中药饮片及中成药的生产及销售。该分部还从事大健康产业的各种大健康产品的生产及销售及透过线下医疗机构提供中药医疗保健解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":-0.00955},{"month":2,"riseRate":0.666667,"avgChangeRate":0.108445},{"month":3,"riseRate":0.333333,"avgChangeRate":0.008801},{"month":4,"riseRate":0.393939,"avgChangeRate":0.016282},{"month":5,"riseRate":0.558824,"avgChangeRate":0.076578},{"month":6,"riseRate":0.411765,"avgChangeRate":-0.020802},{"month":7,"riseRate":0.5,"avgChangeRate":0.003537},{"month":8,"riseRate":0.352941,"avgChangeRate":-0.000616},{"month":9,"riseRate":0.5,"avgChangeRate":-0.021851},{"month":10,"riseRate":0.470588,"avgChangeRate":-0.02131},{"month":11,"riseRate":0.470588,"avgChangeRate":0.031688},{"month":12,"riseRate":0.454545,"avgChangeRate":0.006851}],"exchange":"SEHK","name":"中国中药","nameEN":"TRAD CHI MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国中药(00570)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国中药(00570)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国中药,00570,中国中药股票,中国中药股票老虎,中国中药股票老虎国际,中国中药行情,中国中药股票行情,中国中药股价,中国中药股市,中国中药股票价格,中国中药股票交易,中国中药股票购买,中国中药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国中药(00570)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国中药(00570)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}